Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

88 results
Display

5-aminosalicylic acid in the management of ulcerative colitis

Lee DK

  • KMID: 1693241
  • J Korean Surg Soc.
  • 1992 Mar;42(3):348-351.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?

Jeon SR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study

Suzuki Y, Iida M, Ito H, Saida I, Hibi T

BACKGROUND/AIMS: The therapeutic effect of mesalamine is considered to be dose-dependent; however, no consensus has been reached regarding the optimal doses for individual patients. This study aimed to provide new...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Pyoderma Gangrenosum Associated with Ulcerative Colitis

Yoon YH, Choe SW, Kim MN, Ro BI

  • KMID: 2116108
  • Korean J Dermatol.
  • 2004 Jun;42(6):771-773.
We present a case of pyoderma gangrenosum associated with ulcerative colitis. The patients, a 21-year-old women has suffered from skin defect on the left chest and pubic area since 7...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ureteral Obstruction Caused by Crohn's Disease

Kim HS, Cheon SY, Oh HK, Jeong YB, Kim YG

  • KMID: 2292532
  • Korean J Urol.
  • 2002 Dec;43(12):1100-1103.
Obstructive uropathy with hydronephrosis is a well-known complication of Crohn's disease. This complication is treacherous, since symptoms of urinary tract disease are mostly absent. Inflammatory ureteral engagement should always be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recurrent Eosinophilic Pneumonia Associated with Mesalazine Suppository in a Patient with Ulcerative Colitis

Park M, Lee J, Kang SB, Park Y

Mesalazine suppositories are widely used to treat ulcerative colitis and have a guaranteed safety profile, but although rare, they can cause pulmonary toxicity. A 35-year-old woman with ulcerative colitis was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease

Yi GC, Yoon KH, Hwang JB

  • KMID: 2315351
  • Pediatr Gastroenterol Hepatol Nutr.
  • 2012 Dec;15(4):272-275.
We report here a case of drug-induced acute pancreatitis proved by elimination and single, low dose challenge test in a child with Crohn disease. A 14-year-old boy with moderate/severe Crohn...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Focal Lymphoid Hyperplasia of the Rectum Presented with Hematochezia

Lee CK, Koh JJ, Koh YH, Oh JH, Lim SH, Kim NY, Lee KH, Yang DH, Choi SY, Lee JS

  • KMID: 2084114
  • Korean J Gastrointest Endosc.
  • 1997 Oct;17(5):702-707.
Pseudolymphoma or benign lymphoid hyperplasia is an unusual pathologic entity representing lymphoid hyperplasia, which is sometimes not easily classified as reactive or neoplasic. It occurs in a wide variety of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide

Yeo J, Woo HS, Lee SM, Kim YJ, Kwon KA, Park DK, Kim JH, Kim KO, Chung JW

Oral 5-aminosalicylic acid agents (mesalazine and sulfasalazine) and azathioprine are the mainstays of treatment for inflammatory bowel disease. Reports of pulmonary toxicity induced by oral 5-aminosalicylic acid agents or azathioprine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diverticular Disease: An Update on Pathogenesis and Management

Rezapour M, Ali S, Stollman N

Diverticular disease is one of the most common conditions in the Western world and one of the most common findings identified at colonoscopy. Recently, there has been a significant paradigm...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chemoprevention of Colorectal Cancer in Inflammatory Bowel Disease

Han SH, Lee J

The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease. Surveillance colonoscopy has not been shown to prolong survival and rates of interval cancer are reported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?

Kim YS

Recently, the incidence and prevalence of inflammatory bowel disease (IBD) have been increasing in worldwide, especially in Asian area. IBD is a chronic and progressive disease eventually causing bowel damage....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Nonspecific Interstitial Pneumonia in a Patient with Ulcerative Colitis

Noh YW, Baik EK, Ryu YJ, Kim SE, Lee JH, Sim SS, Lee SN, Chun EM

Pulmonary complications of ulcerative colitis are relatively uncommon and may present as a variety of disorders. Ulcerative colitis-related interstitial lung disease is extremely rare. There are a few case reports...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Topical Tacrolimus Resulting in a Marked Resolution of Perianal Crohn's Disease

Park MH, Choi WJ, Hwang JB

  • KMID: 2275225
  • Korean J Pediatr Gastroenterol Nutr.
  • 2005 Mar;8(1):70-75.
Crohn's disease of the perineum is notably resistant to treatment. We describe our experiences of tacrolimus ointment application in three patients with intractable perianal Crohn's disease. At the time of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Novel Oral Anticoagulant to Treat Pulmonary Thromboembolism in Patient with Ulcerative Colitis Superinfected Cytomegalovirus Colitis

Kim SH, Jang S, Sung Y, Park JK, Park Y, Yun J, Kang SB

Crohn's disease and ulcerative colitis are the two major types of inflammatory bowel disease, and affect mainly the gastrointestinal tract but also have extraintestinal sequelae, such as arterial and venous...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy

Saito D, Hayashida , Sato T, Minowa S, Ikezaki O, Mitsui T, Miura M, Sakuraba A, Hisamatsu

BACKGROUND/AIMS: Mesalazine is an effective drug for treating ulcerative colitis (UC), but causes allergic symptoms in a few cases. Therefore, the objective of this study was to evaluate the usefulness...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Pyoderma Gangrenosum with Ulcerative Colitis Treated with Mesalazine

Lee JI, Park HJ, Lee JY, Cho BK

Pyoderma gangrenosum (PG) manifests as recurrent deep ulceration of the skin and PG is associated with a variety of disorders. Approximately 30% of the cases of PG develop in patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Medical Treatments of Intestinal Behcet's Disease: An Update

Lee HW, Kim WH, Cheon JH

Behcet's disease (BD) is a systemic immunological disorder characterized by recurrent mucosal ulcerative lesions including oral and genital ulcerations in association with skin and ocular involvements. BD also can involve...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Advances in ulcerative colitis therapy

Jeen YT, Kim J

  • KMID: 2257258
  • Korean J Med.
  • 2009 Jun;76(6):654-660.
Ulcerative colitis is an idiopathic inflammatory bowel disease characterized by colonic mucosal inflammation and chronic relapsing episodes. The initial therapeutic approach depends on both the extent of colonic involvement and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Segmental Colitis Associated with Diverticular Disease

Ahn SB, Han DS, Park HS, Kim TY, Eun CS, Jeon YC, Sohn JH

Segmental colitis associated with diverticular disease (SCAD) is a colonic inflammatory disorder with localized non-granulomatous inflammation at sigmoid colon, and associated with colonic diverticulosis. SCAD is an apparently uncommon disorder...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr